Literature DB >> 27546839

Esophageal Cancer.

Benjamin R Alsop1, Prateek Sharma2.   

Abstract

Esophageal cancer carries a poor prognosis among gastrointestinal malignancies. Although esophageal squamous cell carcinoma predominates worldwide, Western nations have seen a marked rise in the incidence of esophageal adenocarcinoma that parallels the obesity epidemic. Efforts directed toward early detection have been difficult, given that dysplasia and early cancer are generally asymptomatic. However, significant advances have been made in the past 10 to 15 years that allow for endoscopic management and often cure in early stage esophageal malignancy. New diagnostic imaging technologies may provide a means by which cost-effective, early diagnosis of dysplasia allows for definitive therapy and ultimately improves the overall survival among patients. Published by Elsevier Inc.

Entities:  

Keywords:  Barrett’s esophagus; Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; Esophagus cancer

Mesh:

Year:  2016        PMID: 27546839     DOI: 10.1016/j.gtc.2016.04.001

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  61 in total

Review 1.  Pathology of esophageal cancer and Barrett's esophagus.

Authors:  Shilpa Jain; Sadhna Dhingra
Journal:  Ann Cardiothorac Surg       Date:  2017-03

2.  Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combination.

Authors:  Pan Pan; Daniel S Peiffer; Yi-Wen Huang; Kiyoko Oshima; Gary D Stoner; Li-Shu Wang
Journal:  J Berry Res       Date:  2018-05-17       Impact factor: 2.352

3.  Endobronchial ultrasound in esophageal cancer - when upper gastrointestinal endoscopy is not enough.

Authors:  Lília Maia Santos; Márcia Jacomelli; Paulo Rogério Scordamaglio; Paulo Francisco Guerreiro Cardoso; Viviane Rossi Figueiredo
Journal:  J Bras Pneumol       Date:  2019-06-27       Impact factor: 2.624

4.  Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer.

Authors:  Nabil F Saba; Seth Force; Charley Staley; Felix Fernandez; Field Willingham; Allan Pickens; Kenneth Cardona; Zhengjia Chen; Laura Goff; Dana Cardin; Eric Lambright; Jon Nesbitt; Alyssa Krasinskas; Kristin Higgins; R Donald Harvey; Taofeek Owonikoko; Suresh S Ramalingam; Dong M Shin; Jonathan J Beitler; Bassel F El-Rayes; Safia Salaria; Wael El-Rifai; Jerome Landry; A B Chakravarthy
Journal:  Am J Clin Oncol       Date:  2019-04       Impact factor: 2.339

5.  Long Term Outcome in Patients with Esophageal Stenting for Cancer Esophagus - Our Experience at a Rural Hospital of Punjab, India.

Authors:  Parvinder Singh; Abhitesh Singh; Anantbir Singh; Ghansham Sharma; Parmod Kumar Bhatia; Amarjeet Singh Grover
Journal:  J Clin Diagn Res       Date:  2016-12-01

6.  Hand grip strength as a predictor of postoperative complications in esophageal cancer patients undergoing esophagectomy.

Authors:  Shinsuke Sato; Erina Nagai; Yusuke Taki; Masaya Watanabe; Yuki Watanabe; Kiyokaze Nakano; Hiroyuki Yamada; Takuya Chiba; Yuichiro Ishii; Hiroshi Ogiso; Masakazu Takagi
Journal:  Esophagus       Date:  2017-07-13       Impact factor: 4.230

7.  Microflora composition in the gastrointestinal tract in patients with Barrett's esophagus.

Authors:  Ikenna Okereke; Catherine Hamilton; Gabriel Reep; Timothy Krill; Adam Booth; Yezaz Ghouri; Vikram Jala; Clark Andersen; Richard Pyles
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 8.  Involvement of long non-coding RNAs in the progression of esophageal cancer.

Authors:  Wenhua Xue; Yuanyuan Zheng; Zhibo Shen; Lifeng Li; Zhirui Fan; Wenbin Wang; Zijia Zhu; Yunkai Zhai; Jie Zhao; Quancheng Kan
Journal:  Cancer Commun (Lond)       Date:  2021-02-19

9.  ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer.

Authors:  Feng He; Hang Xiao; Yixin Cai; Ni Zhang
Journal:  Cell Commun Signal       Date:  2021-05-12       Impact factor: 5.712

10.  Knockdown of lncRNA TUC338 inhibits esophageal cancer cells migration and invasion.

Authors:  Ting Qian; Hui Zhang; Shaorong Yu; Zhenzhang Chen; Hui Jia; Fanyu Peng; Guochun Cao; Jianwei Lu; Delin Liu; Dawei Sun
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.